Literature DB >> 20842342

[Functional and molecular imaging of breast tumors].

K Pinker1, P Brader, G Karanikas, K El-Rabadi, W Bogner, S Gruber, M Reisegger, S Trattnig, T H Helbich.   

Abstract

Molecular imaging is concerned with the presentation, description and quantification of biological and physiological processes at the cellular and molecular level. Most recently molecular imaging has started to become established in breast diagnostics. This review article will give an overview of procedures which are either in the preclinical development stage or which have already become clinically established. Molecular nuclear medicine breast imaging (breast-specific gamma imaging [BSGI] and positron emission mammography [PEM]) together with specific radiotracers and contrast media will be discussed. The possibilities for magnetic resonance imaging in functional (DWI) and metabolic (MRSI) imaging of breast lesions and the combined application of nuclear medicine and magnetic resonance imaging (PET/MRI) will be explained. Furthermore, an overview on the preclinical procedure and the possible clinical applications of optical and photoacoustic imaging will be given.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842342     DOI: 10.1007/s00117-010-2014-9

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  117 in total

1.  Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.

Authors:  Christiane K Kuhl; Hans H Schild; Nuschin Morakkabati
Journal:  Radiology       Date:  2005-09       Impact factor: 11.105

Review 2.  Advances in breast imaging: magnetic resonance imaging.

Authors:  Lia Bartella; Elizabeth A Morris
Journal:  Curr Oncol Rep       Date:  2006-01       Impact factor: 5.075

3.  Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET.

Authors:  Peter M Smith-Jones; David Solit; Farzana Afroze; Neal Rosen; Steven M Larson
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

4.  A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography.

Authors:  F Scopinaro; O Schillaci; W Ussof; K Nordling; R Capoferro; G De Vincentis; R Danieli; M Ierardi; V Picardi; R Tavolaro; A C Colella
Journal:  Anticancer Res       Date:  1997 May-Jun       Impact factor: 2.480

5.  Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus.

Authors:  David P Eisenberg; Prasad S Adusumilli; Karen J Hendershott; Sun Chung; Zhenkun Yu; Mei-Ki Chan; Michael Hezel; Richard J Wong; Yuman Fong
Journal:  Ann Surg       Date:  2006-06       Impact factor: 12.969

6.  Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience.

Authors:  Daniel Floery; Thomas H Helbich; Christopher C Riedl; Silvia Jaromi; Michael Weber; Sepp Leodolter; Michael H Fuchsjaeger
Journal:  Invest Radiol       Date:  2005-06       Impact factor: 6.016

7.  The value of high-field MRI (3T) in the assessment of sellar lesions.

Authors:  K Pinker; A Ba-Ssalamah; S Wolfsberger; V Mlynarik; E Knosp; S Trattnig
Journal:  Eur J Radiol       Date:  2005-06       Impact factor: 3.528

Review 8.  Imaging breast cancer.

Authors:  Lia Bartella; Clare S Smith; D David Dershaw; Laura Liberman
Journal:  Radiol Clin North Am       Date:  2007-01       Impact factor: 2.303

9.  Scintimammography with dedicated breast camera detects and localizes occult carcinoma.

Authors:  Leonard R Coover; Gina Caravaglia; Phyllis Kuhn
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

10.  Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology.

Authors:  J Emmering; N C Krak; J J M Van der Hoeven; M D Spreeuwenberg; J W R Twisk; S Meijer; H M Pinedo; O S Hoekstra
Journal:  Ann Oncol       Date:  2008-06-13       Impact factor: 32.976

View more
  1 in total

1.  High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?

Authors:  K Pinker-Domenig; W Bogner; S Gruber; H Bickel; S Duffy; M Schernthaner; P Dubsky; U Pluschnig; M Rudas; S Trattnig; T H Helbich
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.